Direct visualization of Ebola virus fusion triggering in the endocytic pathway

mBio

Volumn 7, Issue 1, 2016, Pages

  Spence, Jennifer S ^a   Krause, Tyler B ^a   Mittler, Eva ^a   Jangra, Rohit K ^a   Chandran, Kartik ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; NIEMANN PICK C1 PROTEIN; RAB7 PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN; CARRIER PROTEIN; ENVELOPE GLYCOPROTEIN, EBOLA VIRUS; MEMBRANE PROTEIN; NPC1 PROTEIN, HUMAN; PROTEIN BINDING; VIRUS ENVELOPE PROTEIN;

ANIMAL CELL; ARTICLE; BINDING SITE; CELL SURFACE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; EBOLAVIRUS; ENDOSOME; HUMAN; HUMAN CELL; MOLECULAR IMAGING; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; VIRION; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS ENVELOPE; VIRUS GENOME; VIRUS RELEASE; CELL LINE; HOST PATHOGEN INTERACTION; METABOLISM; PHYSIOLOGY; PROCEDURES; VIROLOGY;

CARRIER PROTEINS; CELL LINE; EBOLAVIRUS; ENDOSOMES; HOST-PATHOGEN INTERACTIONS; HUMANS; MEMBRANE GLYCOPROTEINS; PROTEIN BINDING; VIRAL ENVELOPE PROTEINS; VIROLOGY; VIRUS INTERNALIZATION;

EID: 84960157960     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.01857-15     Document Type: Article

References (65)

1. Geisbert TW, Jahrling PB. 1995. Differentiation of filoviruses by electron microscopy. Virus Res 39:129–150. http://dx.doi.org/10.1016/0168-1702(95)00080-1.
2. Huang Y, Xu L, Sun Y, Nabel GJ. 2002. The assembly of Ebola virus nucleocapsid requires virion-associated proteins 35 and 24 and posttranslational modification of nucleoprotein. Mol Cell 10:307–316. http://dx.doi.org/10.1016/S1097-2765(02)00588-9.
3. Watanabe S, Noda T, Kawaoka Y. 2006. Functional mapping of the nucleoprotein of Ebola virus. J Virol 80:3743–3751. http://dx.doi.org/10.1128/JVI.80.8.3743-3751.2006.
4. Booth TF, Rabb MJ, Beniac DR. 2013. How do filovirus filaments bend without breaking? Trends Microbiol 21:583–593. http://dx.doi.org/10.1016/j.tim.2013.08.001.
5. Sanchez A, Yang ZY, Xu L, Nabel GJ, Crews T, Peters CJ. 1998. Biochemical analysis of the secreted and virion glycoproteins of Ebola virus. J Virol 72:6442–6447.
6. GallaherWR. 1996. Similar structural models of the transmembrane proteins of Ebola and avian sarcoma viruses. Cell 85:477–478. http://dx.doi.org/10.1016/S0092-8674(00)81248-9.
7. Lee JE, Fusco ML, Hessell AJ, Oswald WB, Burton DR, Saphire EO. 2008. Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor. Nature 454:177–182. http://dx.doi.org/10.1038/nature07082.
8. Weissenhorn W, Calder LJ, Wharton SA, Skehel JJ, Wiley DC. 1998. The central feature of the membrane fusion subunit from the Ebola virus glycoprotein is a long triple-stranded coiled coil. Proc Natl Acad Sci U S A 95:6032–6036. http://dx.doi.org/10.1073/pnas.95.11.6032.
9. Malashkevich VN, Schneider BJ, McNally ML, Milhollen MA, Pang JX, Kim PS. 1999. Core structure of the envelope glycoprotein GP2 from Ebola virus at 1.9-Å resolution. Proc Natl Acad Sci U S A 96:2662–2667. http://dx.doi.org/10.1073/pnas.96.6.2662.
10. White JM, Delos SE, Brecher M, Schornberg K. 2008. Structures and mechanisms of viral membrane fusion proteins: multiple variations on a common theme. Crit Rev Biochem Mol Biol 43:189–219. http://dx.doi.org/10.1080/10409230802058320.
11. Alvarez CP, Lasala F, Carrillo J, Muñiz O, Corbí AL, Delgado R. 2002. C-type lectins dc-sign and l-sign mediate cellular entry by Ebola virus in cis and in trans. J Virol 76:6841–6844. http://dx.doi.org/10.1128/JVI.76.13.6841-6844.2002.
12. Simmons G, Reeves JD, Grogan CC, Vandenberghe LH, Baribaud F, Whitbeck JC, Burke E, Buchmeier MJ, Soilleux EJ, Riley JL, Doms RW, Bates P, Pöhlmann S. 2003. Dc-sign and dc-signr bind Ebola glycoproteins and enhance infection of macrophages and endothelial cells. Virology 305:115–123. http://dx.doi.org/10.1006/viro.2002.1730.
13. Matsuno K, Nakayama E, Noyori O, Marzi A, Ebihara H, Irimura T, Feldmann H, Takada A. 2010. C-type lectins do not act as functional receptors for filovirus entry into cells. Biochem Biophys Res Commun 403:144–148. http://dx.doi.org/10.1016/j.bbrc.2010.10.136.
14. Shimojima M, Takada A, Ebihara H, Neumann G, Fujioka K, Irimura T, Jones S, Feldmann H, Kawaoka Y. 2006. Tyro3 family-mediated cell entry of Ebola and Marburg viruses. J Virol 80:10109–10116. http://dx.doi.org/10.1128/JVI.01157-06.
15. Kondratowicz AS, Lennemann NJ, Sinn PL, Davey RA, Hunt CL, Moller-Tank S, Meyerholz DK, Rennert P, Mullins RF, Brindley M, Sandersfeld LM, Quinn K, Weller M, McCray PB, Jr, Chiorini J, Maury W. 2011. T-cell immunoglobulin and mucin domain 1 (TIM-1) is a receptor for Zaire Ebolavirus and Lake Victoria Marburgvirus. Proc Natl Acad Sci U S A 108:8426–8431. http://dx.doi.org/10.1073/pnas.1019030108.
16. Saeed MF, Kolokoltsov AA, Albrecht T, Davey RA. 2010. Cellular entry of Ebola virus involves uptake by a macropinocytosis-like mechanism and subsequent trafficking through early and late endosomes. PLoS Pathog 6:e1001110. http://dx.doi.org/10.1371/journal.ppat.1001110.
17. Nanbo A, Imai M, Watanabe S, Noda T, Takahashi K, Neumann G, Halfmann P, Kawaoka Y. 2010. Ebolavirus is internalized into host cells via macropinocytosis in a viral glycoprotein-dependent manner. PLoS Pathog 6:e1001121. http://dx.doi.org/10.1371/journal.ppat.1001121.
18. Mulherkar N, Raaben M, de la Torre JC, Whelan SP, Chandran K. 2011. The Ebola virus glycoprotein mediates entry via a non-classical dynamindependent macropinocytic pathway. Virology 419:72–82. http://dx.doi.org/10.1016/j.virol.2011.08.009.
19. Chandran K, Sullivan NJ, Felbor U, Whelan SP, Cunningham JM. 2005. Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection. Science 308:1643–1645. http://dx.doi.org/10.1126/science.1110656.
20. Carette JE, Raaben M, Wong AC, Herbert AS, Obernosterer G, Mulherkar N, Kuehne AI, Kranzusch PJ, Griffin AM, Ruthel G, Dal Cin P, Dye JM, Whelan SP, Chandran K, Brummelkamp TR. 2011. Ebola virus entry requires the cholesterol transporter Niemann-pick C1. Nature 477: 340–343. http://dx.doi.org/10.1038/nature10348.
21. Côté M, Misasi J, Ren T, Bruchez A, Lee K, Filone CM, Hensley L, Li Q, Ory D, Chandran K, Cunningham J. 2011. Small molecule inhibitors reveal Niemann-pick C1 is essential for Ebola virus infection. Nature 477: 344–348. http://dx.doi.org/10.1038/nature10380.
22. Miller EH, Obernosterer G, Raaben M, Herbert AS, Deffieu MS, Krishnan A, Ndungo E, Sandesara RG, Carette JE, Kuehne AI, Ruthel G, Pfeffer SR, Dye JM, Whelan SP, Brummelkamp TR, Chandran K. 2012. Ebola virus entry requires the host-programmed recognition of an intra-cellular receptor. EMBO J 31:1947–1960. http://dx.doi.org/10.1038/emboj.2012.53.
23. Bale S, Liu T, Li S, Wang Y, Abelson D, Fusco M, Woods VL, Jr., Saphire EO. 2011. Ebola virus glycoprotein needs an additional trigger, beyond proteolytic priming for membrane fusion. PLoS Negl Trop Dis 5:e1395. http://dx.doi.org/10.1371/journal.pntd.0001395.
24. Shoemaker CJ, Schornberg KL, Delos SE, Scully C, Pajouhesh H, Olinger GG, Johansen LM, White JM. 2013. Multiple cationic amphiphiles induce a Niemann-pick C phenotype and inhibit Ebola virus entry and infection. PLoS One 8:e56265. http://dx.doi.org/10.1371/journal.pone.0056265.
25. Takada A, Robison C, Goto H, Sanchez A, Murti KG, Whitt MA, Kawaoka Y. 1997. A system for functional analysis of Ebola virus glycoprotein. Proc Natl Acad Sci U S A 94:14764–14769. http://dx.doi.org/10.1073/pnas.94.26.14764.
26. Kleinfelter LM, Jangra RK, Jae LT, Herbert AS, Mittler E, Stiles KM, Wirchnianski AS, Kielian M, Brummelkamp TR, Dye JM, Chandran K. 2015. Haploid genetic screen reveals a profound and direct dependence on cholesterol for hantavirus membrane fusion. mBio 6:e00801-15. http://dx.doi.org/10.1128/mBio.00801-15.
27. Shaner NC, Lambert GG, Chammas A, Ni Y, Cranfill PJ, Baird MA, Sell BR, Allen JR, Day RN, Israelsson M, Davidson MW, Wang J. 2013. A bright monomeric green fluorescent protein derived from Branchiostoma lanceolatum. Nat Methods 10:407–409. http://dx.doi.org/10.1038/nmeth.2413.
28. Whelan SP, Ball LA, Barr JN, Wertz GT. 1995. Efficient recovery of infectious vesicular virus entirely from cDNA clones. Proc Natl Acad SciU S A 92:8388–8392. http://dx.doi.org/10.1073/pnas.92.18.8388.
29. Jeffers SA, Sanders DA, Sanchez A. 2002. Covalent modifications of the Ebola virus glycoprotein. J Virol 76:12463–12472. http://dx.doi.org/10.1128/JVI.76.24.12463-12472.2002.
30. Kaletsky RL, Simmons G, Bates P. 2007. Proteolysis of the Ebola virus glycoproteins enhances virus binding and infectivity. J Virol 81: 13378–13384. http://dx.doi.org/10.1128/JVI.01170-07.
31. Stegmann T, Morselt HW, Scholma J, Wilschut J. 1987. Fusion of influenza virus in an intracellular acidic compartment measured by fluorescence dequenching. Biochim Biophys Acta 904:165–170. http://dx.doi.org/10.1016/0005-2736(87)90100-3.
32. Lakadamyali M, Rust MJ, Babcock HP, Zhuang X. 2003. Visualizing infection of individual influenza viruses. Proc Natl Acad Sci U S A 100: 9280–9285. http://dx.doi.org/10.1073/pnas.0832269100.
33. Sieczkarski SB, Whittaker GR. 2003. Differential requirements of Rab5 and Rab7 for endocytosis of influenza and other enveloped viruses. Traffic 4:333–343. http://dx.doi.org/10.1034/j.1600-0854.2003.00090.x.
34. Johannsdottir HK, Mancini R, Kartenbeck J, Amato L, Helenius A. 2009. Host cell factors and functions involved in vesicular stomatitis virus entry. J Virol 83:440–453. http://dx.doi.org/10.1128/JVI.01864-08.
35. Schornberg K, Matsuyama S, Kabsch K, Delos S, Bouton A, White J. 2006. Role of endosomal cathepsins in entry mediated by the Ebola virus glycoprotein. J Virol 80:4174–4178. http://dx.doi.org/10.1128/JVI.80.8.4174-4178.2006.
36. Wool-Lewis RJ, Bates P. 1998. Characterization of Ebola virus entry by using pseudotyped viruses: identification of receptor-deficient cell lines. J Virol 72:3155–3160.
37. Sanchez A. 2007. Analysis of filovirus entry into vero E6 cells, using inhibitors of endocytosis, endosomal acidification, structural integrity, and cathepsin (B and L) activity. J Infect Dis 196(Suppl 2):S364–S371. http://dx.doi.org/10.1086/520597.
38. Turk V, Stoka V, Vasiljeva O, Renko M, Sun T, Turk B, Turk D. 2012. Cysteine cathepsins: from structure, function and regulation to new frontiers. Biochim Biophys Acta 1824:68–88. http://dx.doi.org/10.1016/j.bbapap.2011.10.002.
39. Gregory SM, Harada E, Liang B, Delos SE, White JM, Tamm LK. 2011. Structure and function of the complete internal fusion loop from Ebolavirus glycoprotein 2. Proc Natl Acad Sci U S A 108:11211–11216. http://dx.doi.org/10.1073/pnas.1104760108.
40. Harrison JS, Higgins CD, Chandran K, Lai JR. 2011. Designed protein mimics of the Ebola virus glycoprotein GP2 α-helical bundle: stability and pH effects. Protein Sci 20:1587–1596. http://dx.doi.org/10.1002/pro.688.
41. Misasi J, Chandran K, Yang JY, Considine B, Filone CM, Côté M, Sullivan N, Fabozzi G, Hensley L, Cunningham J. 2012. Filoviruses require endosomal cysteine proteases for entry but exhibit distinct protease preferences. J Virol 86:3284–3293. http://dx.doi.org/10.1128/JVI.06346-11.
42. Maruyama T, Rodriguez LL, Jahrling PB, Sanchez A, Khan AS, Nichol ST, Peters CJ, Parren PW, Burton DR. 1999. Ebola virus can be effectively neutralized by antibody produced in natural human infection. J Virol 73:6024–6030.
43. Qiu X, Alimonti JB, Melito PL, Fernando L, Ströher U, Jones SM. 2011. Characterization of Zaire ebolavirus glycoprotein-specific monoclonal antibodies. Clin Immunol 141:218–227. http://dx.doi.org/10.1016/j.clim.2011.08.008.
44. Murin CD, Fusco ML, Bornholdt ZA, Qiu X, Olinger GG, Zeitlin L, Kobinger GP, Ward AB, Saphire EO. 2014. Structures of protective antibodies reveal sites of vulnerability on Ebola virus. Proc Natl Acad SciU S A 111:17182–17187. http://dx.doi.org/10.1073/pnas.1414164111.
45. Audet J, Wong G, Wang H, Gao G, Kobinger GF, Qiu X. 2014. Molecular characterization of the monoclonal antibodies composing ZMAb: a protective cocktail against Ebola virus. Sci Rep 4:6881. http://dx.doi.org/10.1038/srep06881.
46. Krishnan A, Miller EH, Herbert AS, Ng M, Ndungo E, Whelan SP, Dye JM, Chandran K. 2012. Niemann-pick C1 (NPC1)/NPC1-like chimeras define sequences critical for NPC1’s function as a filovirus entry receptor. Viruses 4:2471–2484. http://dx.doi.org/10.3390/v4112471.
47. Manicassamy B, Wang J, Jiang H, Rong L. 2005. Comprehensive analysis of Ebola virus GP1 in viral entry. J Virol 79:4793–4805. http://dx.doi.org/10.1128/JVI.79.8.4793-4805.2005.
48. Dube D, Brecher MB, Delos SE, Rose SC, Park EW, Schornberg KL, Kuhn JH, White JM. 2009. The primed Ebolavirus glycoprotein (19-kilodalton GP1,2): sequence and residues critical for host cell binding. J Virol 83:2883–2891. http://dx.doi.org/10.1128/JVI.01956-08.
49. Higgins ME, Davies JP, Chen FW, Ioannou YA. 1999. Niemann-pick C1 is a late endosome-resident protein that transiently associates with lysosomes and the trans-Golgi network. Mol Genet Metab 68:1–13. http://dx.doi.org/10.1006/mgme.1999.2882.
50. Sakurai Y, Kolokoltsov AA, Chen CC, Tidwell MW, Bauta WE, Klugbauer N, Grimm C, Wahl-Schott C, Biel M, Davey RA. 2015. Two-pore channels control Ebola virus host cell entry and are drug targets for disease treatment. Science 347:995–998. http://dx.doi.org/10.1126/science.1258758.
51. Ruas M, Rietdorf K, Arredouani A, Davis LC, Lloyd-Evans E, Koegel H, Funnell TM, Morgan AJ, Ward JA, Watanabe K, Cheng X, Churchill GC, Zhu MX, Platt FM, Wessel GM, Parrington J, Galione A. 2010. Purified TPC isoforms form NAADP receptors with distinct roles in Ca2_ signaling ad endolysosomal trafficking. Curr Biol 20:703–709. http://dx.doi.org/10.1016/j.cub.2010.02.049.
52. Mingo RM, Simmons JA, Shoemaker CJ, Nelson EA, Schornberg KL, D’Souza RS, Casanova JE, White JM. 2015. Ebola virus and severe acute respiratory syndrome coronavirus display late cell entry kinetics: evidence that transport to NPC1+ endolysosomes is a rate-defining step. J Virol 89:2931–2943. http://dx.doi.org/10.1128/JVI.03398-14.
53. Simmons JA, D’Souza RS, Ruas M, Galione A, Casanova JE, White JM. 2015. The ebolavirus glycoprotein directs fusion through NPC1+endolysosomes. J Virol 90:605–610. http://dx.doi.org/10.1128/JVI.01828-15.
54. Brecher M, Schornberg KL, Delos SE, Fusco ML, Saphire EO, White JM. 2012. Cathepsin cleavage potentiates the Ebola virus glycoprotein to undergo a subsequent fusion-relevant conformational change. J Virol 86: 364–372. http://dx.doi.org/10.1128/JVI.05708-11.
55. Gregory SM, Larsson P, Nelson EA, Kasson PM, White JM, Tamm LK. 2014. Ebolavirus entry requires a compact hydrophobic fist at the tip of the fusion loop. J Virol 88:6636–6649. http://dx.doi.org/10.1128/JVI.00396-14.
56. Saeed MF, Kolokoltsov AA, Freiberg AN, Holbrook MR, Davey RA. 2008. Phosphoinositide-3 kinase-Akt pathway controls cellular entry of Ebola virus. PLoS Pathog 4:e1000141. http://dx.doi.org/10.1371/journal.ppat.1000141.
57. Otterstrom JJ, Brandenburg B, Koldijk MH, Juraszek J, Tang C, Mashaghi S, Kwaks T, Goudsmit J, Vogels R, Friesen RH, van Oijen AM. 2014. Relating influenza virus membrane fusion kinetics to stoichiometry of neutralizing antibodies at the single-particle level. Proc Natl Acad Sci U S A 111:—E5143–E5148. http://dx.doi.org/10.1073/pnas.1411755111.
58. Throsby M, van den Brink E, Jongeneelen M, Poon LL, Alard P, Cornelissen L, Bakker A, Cox F, van Deventer E, Guan Y, Cinatl J, ter Meulen J, Lasters I, Carsetti R, Peiris M, de Kruif J, Goudsmit J. 2008. Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM_ memory B cells. PLoS One 3:e3942. http://dx.doi.org/10.1371/journal.pone.0003942.
59. Ekiert DC, Friesen RHE, Bhabha G, Kwaks T, Jongeneelen M, Yu W, Ophorst C, Cox F, Korse HJWM, Brandenburg B, Vogels R, Brakenhoff JPJ, Kompier R, Koldijk MH, Cornelissen LAHM, Poon LLM, Peiris M, Koudstaal W, Wilson IA, Goudsmit J. 2011. A highly conserved neutralizing epitope on group 2 influenza A viruses. Science 333:843–850. http://dx.doi.org/10.1126/science.1204839.
60. Wong AC, Sandesara RG, Mulherkar N, Whelan SP, Chandran K. 2010. A forward genetic strategy reveals destabilizing mutations in the Ebolavirus glycoprotein that alters its protease dependence during cell entry. J Virol 84:163–175. http://dx.doi.org/10.1128/JVI.01832-09.
61. Mothes W, Boerger AL, Narayan S, Cunningham JM, Young JA. 2000. Retroviral entry mediated by receptor priming and lowpHtriggering of an envelope glycoprotein. Cell 103:679–689. http://dx.doi.org/10.1016/S0092-8674(00)00170-7.
62. Mali P, Yang L, Esvelt KM, Aach J, Guell M, DiCarlo JE, Norville JE, Church GM. 2013. RNA-guided human genome engineering via Cas9. Science 339:823–826. http://dx.doi.org/10.1126/science.1232033.
63. Mazor Y, Barnea I, Keydar I, Benhar I. 2007. Antibody internalization studied using a novel IgG binding toxin fusion. J Immunol Methods 321: 41–59. http://dx.doi.org/10.1016/j.jim.2007.01.008.
64. Karauzum H, Chen G, Abaandou L, Mahmoudieh M, Boroun AR, Shulenin S, Devi VS, Stavale E, Warfield KL, Zeitlin L, Roy CJ, Sidhu SS, Aman MJ. 2012. Synthetic human monoclonal antibodies toward staphylococcal enterotoxin B (SEB) protective against toxic shock syndrome. J Biol Chem 287:25203–25215. http://dx.doi.org/10.1074/jbc.M112.364075.
65. Bornholdt ZA, et al. mBio, in press.